Key Market Indicators
Sales of digestive system disorder medicines in Latvia are set to reach nearly $78 million by 2026, according to research. The market increased by an average of 4.9% annually between 2006 and 2021, reaching $69.1 million in 2021, making Latvia the 25th largest market globally. Slovenia was the largest in the region, with $69.1 million in sales. Japan, South Korea and Canada followed, in second, third and fourth place.
